Oncolab provides an innovation cancer screening test called the Anti-Malignin Antibody in Serum test or AMAS for short. AMAS is blood serum test which looks for a very specific antibody which is elevated in people's bodies when there is an active malignancy present.
| Website | http://www.oncolabinc.com |
| Revenue | $1 million |
| Employees | 8 (6 on RocketReach) |
| Address | 36 the Fenway, Boston, Massachusetts 02215, US |
| Phone | +1 617-536-3030 |
| Technologies |
JavaScript
,
HTML
,
Google Analytics
+6 more
(view full list)
|
| Industry | Medical Practices, Medical Testing & Clinical Laboratories, Healthcare |
| Web Rank | 3 Million |
| Keywords | Cancer Screening, Cancer Screening Test, Early Cancer Detection, Precision Oncology, Cancer Research, Cancer Diagnostics, Immunodiagnostics, Oncology Diagnostics, Medical Diagnostics, Advanced Cancer Diagnostics, Clinical Diagnostics |
| Competitors | The Janssen Pharmaceutical Companies of Johnson & Johnson, Roche, Merck & Co., Inc., Amgen, Bristol Myers Squibb, Gilead Sciences, Novartis, AbbVie, Lilly India, AstraZeneca +42 more (view full list) |
| SIC | SIC Code 807 Companies, SIC Code 80 Companies |
| NAICS | NAICS Code 62151 Companies, NAICS Code 6215 Companies, NAICS Code 621 Companies, NAICS Code 62 Companies |
Looking for a particular Oncolab, Inc employee's phone or email?
The Oncolab, Inc annual revenue was $1 million in 2026.
Ron Snow is the Director of Marketing of Oncolab, Inc.
6 people are employed at Oncolab, Inc.
Oncolab, Inc is based in Boston, Massachusetts.
The NAICS codes for Oncolab, Inc are [62151, 6215, 621, 62].
The SIC codes for Oncolab, Inc are [807, 80].